Top hit

Funds

Viewpoints by Jean M. Hynes, CFA, Portfolio Manager at Wellington Management

Jean is a portfolio manager and Wellington Management’s healthcare sector team leader for global industry research. Her portfolio management responsibilities include global healthcare sector portfolios and hedge funds. Jean has spent her career specializing in the pharmaceutical and biotechnology industries. She joined Wellington Management in 1991, following her graduation from Wellesley College, where she earned a B.A., and she holds the Chartered Financial Analyst designation.

Filter posts by asset managers and topics.

Select Asset Manager

Select Topic Category

Alternatives
College saving
ESG
ETFs
Fixed income
International equities
Investing basics
Market outlook
Portfolio construction
Retirement planning
U.S. equities

Healthcare investing: economic implications of scientific advancement

What does greater longevity mean for healthcare investing and quality of life? Explore answers to these and other questions about the real meaning of prosperity.

Jean M. Hynes, CFA, Portfolio Manager Wellington Management

Read more

September 13, 2019

Jean M. Hynes, CFA, Portfolio Manager Wellington Management
Vital signs: long/short opportunities in healthcare stocks

Changes in healthcare favor long/short sector specialists, as some companies thrive and others fail to adapt. See why investors in healthcare stocks can’t expect a rising tide to lift all boats.

Jean M. Hynes, CFA, Portfolio Manager Wellington Management

Read more

December 07, 2017

Jean M. Hynes, CFA, Portfolio Manager Wellington Management
Growing pains: why high volatility in healthcare shouldn't last

Healthcare stocks have been under pressure, despite solid fundamentals and sensible valuations. Wellington Management’s Jean M. Hynes, CFA, puts recent price disruptions across the sector in context.

Jean M. Hynes, CFA, Portfolio Manager Wellington Management

Read more

March 01, 2016

Jean M. Hynes, CFA, Portfolio Manager Wellington Management

Explore the latest thinking from our network

Careers
Contact Us

Legal
Privacy Policy
Accessibility
Site map

John Hancock Investment Management LLC is the investment advisor for the closed-end funds.

A widespread health crisis, such as a global pandemic, could cause substantial market volatility, exchange-trading suspensions and closures, affect the ability to complete redemptions, and affect fund performance; for example, the novel coronavirus disease (COVID-19) has resulted in significant disruptions to global business activity. The impact of a health crisis and other epidemics and pandemics that may arise in the future could affect the global economy in ways that cannot necessarily be foreseen at the present time. A health crisis may exacerbate other preexisting political, social, and economic risks. Any such impact could adversely affect the fund’s performance, resulting in losses to your investment.

Mutual funds

© 1999–2020 John Hancock Investment Management Distributors LLC and affiliated companies.
Member FINRA | SIPC, 200 Berkeley Street, Boston, MA 02116

Click here to view a prospectus or summary prospectus. You may also request one from your financial professional or by calling us at 800-225-5291. The prospectus includes investment objectives, risks, fees, expenses, and other information that you should consider carefully before investing.

Some information may not be approved by certain organizations. Please check with your organization before using this information.

ETFs

John Hancock ETFs are distributed by Foreside Fund Services LLC in the United States, and are subadvised by Dimensional Fund Advisors LP in all markets. Foreside is not affiliated with John Hancock Investment Management Distributors LLC or Dimensional Fund Advisors LP.

ETF shares are bought and sold through exchange trading at market price (not NAV), and are not individually redeemed from the fund. Shares may trade at a premium or discount to their NAV in the secondary market. Brokerage commissions will reduce returns.

529

If your state or your designated beneficiary’s state offers a 529 plan, you may want to consider what, if any, potential state income-tax or other state benefits it offers, such as financial aid, scholarship funds, and protection from creditors, before investing. State tax or other benefits should be one of many factors to be considered prior to making an investment decision. Please consult with your financial, tax, or other professional about how these state benefits, if any, may apply to your specific circumstances. You may also contact your state 529 plan or any other 529 education savings plan to learn more about their features. Please contact your financial professional or call 866-222-7498 to obtain a Plan Disclosure Document or prospectus for any of the underlying funds. The Plan Disclosure Document contains complete details on investment objectives, risks, fees, charges, and expenses, as well as more information about municipal fund securities and the underlying investment companies that should be considered before investing. Please read the Plan Disclosure Document carefully prior to investing.

John Hancock Freedom 529 is an education savings plan offered by the Education Trust of Alaska, managed by T. Rowe Price, and distributed by John Hancock Distributors LLC through other broker-dealers that have a selling agreement with John Hancock Distributors LLC. John Hancock Distributors LLC is a member of FINRA and is listed with the Municipal Securities Rulemaking Board (MSRB). © 2020 John Hancock. All rights reserved. Information included in this material is believed to be accurate as of the printing date.

John Hancock Freedom 529

P.O. Box 17603 ■ Baltimore, MD 21297-1603 ■ 866-222-7498 ■ jhinvestments.com/529

529 PLANS ARE NOT FDIC INSURED, MAY LOSE VALUE, AND ARE NOT BANK OR STATE GUARANTEED.

Viewpoints by Jean M. Hynes, CFA, Portfolio Manager at Wellington Management

Healthcare investing: economic implications of scientific advancement

Vital signs: long/short opportunities in healthcare stocks

Growing pains: why high volatility in healthcare shouldn't last

Explore the latest thinking from our network

All Tags